HADD Science Unveils a New Breakthrough in 3D Cell Culture
The 3rd Convergence Seminar, held on August 22nd, revealed an innovative approach to 3D cell culture technology. This seminar was more than just an academic event. It served as a platform to share key achievements of the 'Patient-Specific Convergent Biopharmaceutical Product Development' project, supported by the Ministry of Trade, Industry and Energy, and included practical strategies targeting the multi-trillion-won global bio market.
Everything Changes When the 'Home' of Cells Transforms
The central figure of the day was Professor Heo Chae-jeong (CEO of HADD Science) from Sungkyunkwan University's Department of Biophysics. The core of his presented technology, "Extracellular matrix mediated 3D cellular reconstruction," was both intuitive and innovative. Through this seminar, the Ajou University Convergence Manufacturing Demonstration Project Group showcased a vision beyond mere technology introduction. They discussed cases of convergent biopharmaceutical product development and regulatory overcoming, as well as the potential for AI utilization, presenting a practical roadmap for Korean bio companies to expand overseas. As key technologies for a new leap forward in the Korean bio industry are gradually emerging, HADD Science's ECM-based 3D technology stands at the forefront.
Original Article